Beta 1- and beta 2-adrenoceptor-mediated secretion of amylase from incubated rat parotid gland

Acta Physiologica Scandinavica
B CarlsööR Henriksson


The present in vitro investigation was undertaken in an attempt to obtain further information on beta-adrenoceptor specificity and action in the rat parotid gland, with regard to amylase secretion. The beta 1-selective agonist prenalterol was roughly 800 times more potent than the beta 2-agonist terbutaline, and about 5 times more effective than noradrenaline in evoking amylase release . Propranolol was the most effective inhibitor of amylase release in all experiments. The beta 1-selective antagonist metoprolol and H104 /08 were also effective blockers of maximal noradrenaline- and prenalterol-induced release. The inhibition curves displayed biphasic shapes when amylase secretion was induced by noradrenaline, but not when prenalterol was the secretagogue. The beta 2-antagonist H35 /25 was without effect on maximal noradrenaline- and prenalterol-stimulated secretion. The amylase release evoked by submaximal concentration of terbutaline was inhibited by the two antagonists H35/25 and IPS 339. In another series of experiments propranolol and metoprolol clearly shifted the noradrenaline concentration-response curve to the right, whereas H35/25 was without effect. The results further demonstrate the major importance of the beta 1-a...Continue Reading


Nov 10, 1977·Naunyn-Schmiedeberg's Archives of Pharmacology·E CarlssonB Tångstrand
Mar 1, 1978·British Journal of Pharmacology·B CarlsööR Henriksson
Dec 22, 1977·Biochimica Et Biophysica Acta·D K AuF R Butcher
Jun 1, 1979·Pharmacological Research Communications·C OminiL Puglisi
Nov 1, 1972·Experimental Eye Research·B GrafJ P Faure
May 1, 1974·Analytical Biochemistry·A Danielsson
Nov 1, 1967·Life Sciences·A M LandsH J Buzzo
Jan 1, 1981·Annual Review of Neuroscience·K P MinnemanP B Molinoff
Feb 1, 1981·British Journal of Pharmacology·B CarlsööL A Idahl
Sep 1, 1981·Acta Physiologica Scandinavica·J Hillman, J Lundvall


Jan 1, 1987·Comparative Biochemistry and Physiology. C, Comparative Pharmacology and Toxicology·K Abe
Oct 1, 1987·Acta Physiologica Scandinavica·G JönssonS Sundström
Feb 19, 2010·American Journal of Physiology. Cell Physiology·Ching-Yi WuEileen L Watson
Sep 26, 2000·Experimental and Molecular Pathology·M J GonzálezR O López Solís
Jan 1, 1993·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·G S Bedi
Feb 5, 2011·European Journal of Pharmacology·Kazunori OuchiMitsuru Kawaguchi

Related Concepts

H 35-25, hydrochloride, (+-)-isomer
IPS 339, monohydrochloride, (+-)-isomer
Pamatolol sulfate (2: 1)
Adrenergic beta-Agonists
Adrenergic beta-Antagonists
Norepinephrine, (+, -)-Isomer
Parotid Gland

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.